Goodman Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-129
Closed -$31.5K 118
2026
Q1
$31.5K Hold
129
0.01% 122
2025
Q4
$26.7K Hold
129
0.01% 120
2025
Q3
$23.9K Hold
129
0.01% 123
2025
Q2
$19.7K Hold
129
0.01% 107
2025
Q1
$21.4K Buy
+129
New +$20.2K 0.01% 130
2024
Q4
Sell
-129
Closed -$20.9K 118
2024
Q3
$20.9K Hold
129
0.01% 143
2024
Q2
$18.9K Hold
129
0.01% 138
2024
Q1
$20.4K Hold
129
0.01% 116
2023
Q4
$20.2K Hold
129
0.01% 110
2023
Q3
$20.1K Hold
129
0.01% 113
2023
Q2
$21.4K Hold
129
0.01% 103
2023
Q1
$20K Hold
129
0.01% 100
2022
Q4
$23K Hold
129
0.01% 92
2022
Q3
$21K Sell
129
-91
-41% -$15.4K 0.01% 94
2022
Q2
$39K Buy
+220
New +$39.2K 0.02% 84

Other funds holding JNJ

Goodman Advisory Group's JNJ Position: Q2 2026 in Review

Goodman Advisory Group sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 129 shares — an estimated $31.5K sold.

Goodman Advisory Group first reported a position in JNJ in Q2 2022 and held it in 15 quarters. The position peaked at $39K in Q2 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Goodman Advisory Group reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Goodman Advisory Group sold 129 Johnson & Johnson shares in Q2 2026, an estimated $31.5K.
  • Goodman Advisory Group first reported a position in Johnson & Johnson in Q2 2022 and held it in 15 quarters.
  • Goodman Advisory Group's Johnson & Johnson position peaked at $39K in Q2 2022.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.